News

Filter

Current filters:

None

60 to 69 of 95956 results

Actavis confirms patent challenge for generic Neupro

Actavis confirms patent challenge for generic Neupro

23-08-2014

Ireland-headquartered generics major Actavis on Friday confirmed that it has filed an Abbreviated New…

ActavisGenericsLegalNeuproNeurologicalPatentsRegulationUCBUSA

Hera Therapeutics’ HTI-1968 shuts down HPV that causes most cervical cancer

Hera Therapeutics’ HTI-1968 shuts down HPV that causes most cervical cancer

23-08-2014

Research presented at the 29th Annual International Papillomavirus Conference shows that a therapy being…

Anti-viralsHera Therapeuticshti-1968PharmaceuticalResearchWomen's Health

ViaCyte gets $20 million in deal with Janssen

ViaCyte gets $20 million in deal with Janssen

22-08-2014

Privately held US regenerative medicine company ViaCyte has entered into a rights agreement with Janssen…

BiotechnologyDiabetesEndocrine systemFinancialJanssenJohnson & JohnsonLicensingUSAVC-01ViaCyte

Mylan launches first generic Klor-Con extended-release tablets

Mylan launches first generic Klor-Con extended-release tablets

22-08-2014

US generic drugs major Mylan said today that it has launched potassium chloride extended-release tablets…

GenericsKlor-ConMarkets & MarketingMetabolicsMylanUpsher-SmithUSA

EXPERT VIEW: Pay-for-delay - GSK’s wait is almost over…

EXPERT VIEW: Pay-for-delay - GSK’s wait is almost over…

22-08-2014

If GlaxoSmithKline thought that the demise of the Office of Fair Trading (OFT) on April 1 would bring…

Activist UK LimitedGenericsGlaxoSmithKlineLicensingPatentsPharmaceuticalSeroxatUK

ADHD treatment market set to reach $9.9 billion by 2020

ADHD treatment market set to reach $9.9 billion by 2020

22-08-2014

The attention-deficit hyperactivity disorder (ADHD) therapeutics market value will rise from $6.9 billion…

ADHDEuropeJapanNeurologicalPharmaceuticalPsychiatryUSA

60 to 69 of 95956 results

Back to top